HVIVO

hvivo-logo

hVIVO, a specialty biopharma company with clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. hVIVO changed its name from Retroscreen Virology in April 2015. The business is a plc quoted on the AIM London Stock Exchange (ticker โ€˜HVOโ€™).

#People #Financial #Website #More

HVIVO

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
1988-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.hvivo.com

Total Employee:
501+

Status:
Active

Contact:
+44 20 7756 1300

Email Addresses:
[email protected]

Total Funding:
2.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network



Current Advisors List

charles-winward_image

Charles Winward Non-Executive Member of the Board of Directors @ hVIVO
Board_member

Current Employees Featured

leo-toole_image

Leo Toole
Leo Toole Chief Financial Officer @ hVIVO
Chief Financial Officer

tim-sharpington_image

Tim Sharpington
Tim Sharpington Chief Operating Officer @ hVIVO
Chief Operating Officer
2018-04-01

not_available_image

Rob Lambkin Williams
Rob Lambkin Williams CSO @ hVIVO
CSO

Stock Details


Company's stock symbol is LSE:HVO

Acquisitions List

Date Company Article Price
2014-03-04 Activiomics Activiomics acquired by hVIVO 4 M GBP

Investors List

aquarius-equity-partners_image

Aquarius Equity Partners

Aquarius Equity Partners investment in Series B - hVIVO

Investments List

Date Company Article Money raised
2016-04-28 Imutex hVIVO investment in Seed Round - Imutex 14 M GBP
2015-11-02 PrEP Biopharm hVIVO investment in Series A - PrEP Biopharm 21 M GBP

Official Site Inspections

http://www.hvivo.com Semrush global rank: 3.5 M Semrush visits lastest month: 4.26 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "hVIVO"

About Us | World Leaders in Clinical Trials - hVIVO

In January 2020, hVIVO merged with Open Orphan plc, a rapidly growing niche CRO pharmaceutical services company. On 26 October 2022, Open Orphan plc changed its name โ€ฆSee details»

Executive Leadership Team | hVIVO

HVIVO is led by a dynamic group of experts in their respective fields who are driving excellence throughout the organisation. Leadership Team. Board of Directors. Chief Executive Officer. โ€ฆSee details»

hVIVO - Crunchbase Company Profile & Funding

FluCamp is hVIVO's volunteer recruitment brand, recruiting healthy volunteers for human challenge trials to advance medical research in infectious and โ€ฆSee details»

hVIVO - Products, Competitors, Financials, Employees, โ€ฆ

HVIVO is a specialist contract research organization and is involved in conducting human challenge clinical trials for testing infectious and respiratory disease vaccines and โ€ฆSee details»

hVIVO - Funding, Financials, Valuation & Investors - Crunchbase

HVIVO is a contract virology research company that aims to develop antivirals and vaccines in the field of biomedical research. New. Resources. ... How much funding has this organization โ€ฆSee details»

hVIVO (HVO) Investor Relations Material

Jan 29, 2025 hVIVO plc is a contract research organization (CRO) based in the United Kingdom, specializing in the testing of vaccines and antiviral treatments using human challenge clinical โ€ฆSee details»

hVIVO Company Profile | Management and Employees List

HVIVO Profile and History. Founded in 1989 and headquartered in London, UK, hVIVO is a specialty biopharma company with clinical testing capabilities, that is pioneering a human โ€ฆSee details»

hVIVO Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Oct 29, 2024 hVIVO has 5 employees across 2 locations and £11.03 m in annual revenue in FY 2018. See insights on hVIVO including office locations, competitors, revenue, financials, โ€ฆSee details»

Retroscreen Virology Changes its Name to hVIVO

This name change to hVIVO reflects the organisationโ€™s expanded vision and a new human dimension to the way new therapeutic and diagnostics are discovered and developed. Retroscreen Virology Group plc changes to hVIVO plc, and โ€ฆSee details»

Results Centre | Investor Relations - hVIVO

Jan 29, 2025 At hVIVO, our values are more than just words. They are what define us. 01. One Team. We are a diverse group of individuals working for one team to achieve common goals. Each one of us plays a crucial role in the โ€ฆSee details»

hVIVO a world leader in an expanding niche quietly making progress

Mar 21, 2025 One of hVIVOโ€™s standout strengths is its substantial order book. Moving into 2025, it had secured £67 million in contracted revenue, covering a significant portion of its forecasted โ€ฆSee details»

hVIVO Announces Director Update Amid Oncimmune โ€ฆ

Mar 26, 2025 hVIVO plc is a rapidly growing early-stage Contract Research Organisation (CRO) and the global leader in human challenge trials. The company provides comprehensive clinical โ€ฆSee details»

Corporate Governance Code | Investor Relations - hVIVO

The Company has successfully built a drug development consulting and clinical trial services capability in Europe. While this represents the operating capability of the business, its clients โ€ฆSee details»

hVIVO - Overview, News & Similar companies | ZoomInfo.com

Feb 1, 2023 hVIVO contact info: Phone number: +44 2071180727 Website: www.hvivo.com What does hVIVO do? Founded in 1989 and headquartered in London, UK, hVIVO is a โ€ฆSee details»

hVIVO a world leader in an expanding niche quietly making progress

Mar 21, 2025 hVIVO PLC (AIM:HVO) posted record results for 2024, with revenue up 12% and a bumper 26% EBITDA margin. CEO Mo Khan says hVIVO is targeting £73 million in revenue โ€ฆSee details»

hVIVO plc: Governance, Directors and Executives & Committees ...

Nov 5, 2024 hVIVO plc is a United Kingdom-based specialist contract research organization (CRO). The Company is engaged in testing infectious and respiratory disease vaccines and โ€ฆSee details»

Hvivo revenue rose last year as company diversified services

Apr 10, 2025 Looking ahead, Hvivo is guiding revenue of £73 million for the year, with ebitda profit margins expected to be in the mid-high teens as the company integrates its latest โ€ฆSee details»

Environmental, Social & Governance - hVIVO

At hVIVO, we play an important role in improving global health by supporting the clinical development of medicinal products, especially infectious and respiratory disease products, โ€ฆSee details»

hVIVO a world leader in an expanding niche quietly making progress

Mar 21, 2025 One of hVIVOโ€™s standout strengths is its substantial order book. Moving into 2025, it had secured £67 million in contracted revenue, covering a significant portion of its forecasted โ€ฆSee details»

hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

Dec 20, 2024 In our recent interview with Mo Khan, CEO of hVIVO, we reflected on the companyโ€™s outstanding achievements in 2024 and gained insights into its ambitious roadmap โ€ฆSee details»

linkstock.net © 2022. All rights reserved